{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T04:54:28Z","timestamp":1780116868249,"version":"3.54.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,3]],"date-time":"2019-12-03T00:00:00Z","timestamp":1575331200000},"content-version":"vor","delay-in-days":3715,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1093\/annonc\/mdp053","type":"journal-article","created":{"date-parts":[[2009,6,24]],"date-time":"2009-06-24T01:53:56Z","timestamp":1245808436000},"page":"1697-1702","source":"Crossref","is-referenced-by-count":31,"title":["Validation, revision and extension of the Follicular Lymphoma International Prognostic Index (FLIPI) in a population-based setting"],"prefix":"10.1016","volume":"20","author":[{"given":"S.A.M.","family":"van de Schans","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.W.","family":"Steyerberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.R.","family":"Nijziel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.-J.","family":"Creemers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.L.","family":"Janssen-Heijnen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.J.","family":"van Spronsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdp053_bb0010","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1182\/blood-2003-12-4434","article-title":"Follicular lymphoma international prognostic index","volume":"104","author":"Solal-Celigny","year":"2004","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdp053_bb0015","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jclinepi.2005.08.015","article-title":"Survival estimates of a prognostic classification depended more on year of treatment than on imputation of missing values","volume":"59","author":"van Dijk","year":"2006","journal-title":"J Clin Epidemiol"},{"key":"10.1093\/annonc\/mdp053_bb0020","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0895-4356(02)00539-5","article-title":"Developing a prognostic model in the presence of missing data: an ovarian cancer case study","volume":"56","author":"Clark","year":"2003","journal-title":"J Clin Epidemiol"},{"key":"10.1093\/annonc\/mdp053_bb0025","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.leukres.2005.07.006","article-title":"Correlation of the FLIPI score for follicular lymphoma with period of diagnosis and type of treatment","volume":"30","author":"Arcaini","year":"2006","journal-title":"Leuk Res"},{"key":"10.1093\/annonc\/mdp053_bb0030","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1182\/blood-2006-01-013367","volume":"108","author":"Buske","year":"2006","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdp053_bb0035","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1093\/annonc\/mdh406","article-title":"Predictive value of Follicular Lymphoma International Prognostic Index (FLIPI) in patients with follicular lymphoma at first progression","volume":"15","author":"Montoto","year":"2004","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdp053_bb0040","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1600-0609.2005.00564.x","article-title":"Follicular lymphoma in early stages: high risk of relapse and usefulness of the Follicular Lymphoma International Prognostic Index to predict the outcome of patients","volume":"76","author":"Plancarte","year":"2006","journal-title":"Eur J Haematol"},{"key":"10.1093\/annonc\/mdp053_bb0045","doi-asserted-by":"crossref","first-page":"515","DOI":"10.7326\/0003-4819-130-6-199903160-00016","article-title":"Assessing the generalizability of prognostic information","volume":"130","author":"Justice","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1093\/annonc\/mdp053_bb0050","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"10.1093\/annonc\/mdp053_bb0055","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1093\/oxfordjournals.annonc.a010716","article-title":"Age-specific differences in the diagnostics and treatment of cancer patients aged 50 years and older in the province of Limburg, The Netherlands","volume":"7","author":"de Rijke","year":"1996","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdp053_bb0060","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s002770050521","article-title":"Prevalence of co-morbidity and its relationship to treatment among unselected patients with Hodgkin's disease and non-Hodgkin's lymphoma, 1993\u20131996","volume":"78","author":"van Spronsen","year":"1999","journal-title":"Ann Hematol"},{"key":"10.1093\/annonc\/mdp053_bb0065","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/j.1365-2141.2005.05508.x","article-title":"A population-based study of severity of comorbidity among patients with non-Hodgkin's lymphoma: prognostic impact independent of International Prognostic Index","volume":"129","author":"Janssen-Heijnen","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1093\/annonc\/mdp053_bb0070","series-title":"Cancer Incidence, Care and Survival in the SOUTH of The Netherlands, 1955\u20131999: A Report of the Eindhoven Cancer Registry with Cross Border Implications","author":"Coebergh","year":"2001"},{"key":"10.1093\/annonc\/mdp053_bb0075","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0895-4356(98)00154-1","article-title":"A comparison of the Charlson comorbidity index derived from medical record data and administrative billing data","volume":"52","author":"Kieszak","year":"1999","journal-title":"J Clin Epidemiol"},{"key":"10.1093\/annonc\/mdp053_bb0080","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.critrevonc.2005.04.008","article-title":"Prognostic impact of increasing age and co-morbidity in cancer patients: a population-based approach","volume":"55","author":"Janssen-Heijnen","year":"2005","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1093\/annonc\/mdp053_bb0085","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1016\/j.ejca.2007.08.011","article-title":"COPD in cancer patients: higher prevalence in the elderly, a different treatment strategy in case of primary tumours above the diaphragm, and a worse overall survival in the elderly patient","volume":"43","author":"van de Schans","year":"2007","journal-title":"Eur J Cancer"},{"key":"10.1093\/annonc\/mdp053_bb0090","doi-asserted-by":"crossref","first-page":"3401","DOI":"10.1002\/1097-0258(20001230)19:24<3401::AID-SIM554>3.0.CO;2-2","article-title":"Validation, calibration, revision and combination of prognostic survival models","volume":"19","author":"van Houwelingen","year":"2000","journal-title":"Stat Med"},{"key":"10.1093\/annonc\/mdp053_bb0095","series-title":"Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis","author":"Harell","year":"2001"},{"key":"10.1093\/annonc\/mdp053_bb0100","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/hon.772","article-title":"Prognosis of follicular lymphomas","volume":"24","author":"Luminari","year":"2006","journal-title":"Hematol Oncol"},{"key":"10.1093\/annonc\/mdp053_bb0105","first-page":"783","article-title":"Prognosis of follicular lymphoma: a predictive model based on a retrospective analysis of 987 cases. Intergruppo Italiano Linfomi","volume":"95","author":"Federico","year":"2000","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdp053_bb0110","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/1097-0142(19880201)61:3<441::AID-CNCR2820610306>3.0.CO;2-N","article-title":"Maintenance chlorambucil after CVP in the management of advanced stage, low-grade histologic type non-Hodgkin's lymphoma. A randomized prospective study with an assessment of prognostic factors","volume":"61","author":"Steward","year":"1988","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdp053_bb0115","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1200\/JCO.1999.17.8.2499","article-title":"Low-grade stage III\u2013IV follicular lymphoma: multivariate analysis of prognostic factors in 484 patients\u2013a study of the groupe d'Etude des lymphomes de l'Adulte","volume":"17","author":"Decaudin","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdp053_bb0120","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/sim.2331","article-title":"Dichotomizing continuous predictors in multiple regression: a bad idea","volume":"25","author":"Royston","year":"2006","journal-title":"Stat Med"},{"key":"10.1093\/annonc\/mdp053_bb0125","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1002\/1097-0142(20001215)89:12<2667::AID-CNCR21>3.0.CO;2-P","article-title":"Different age limits for elderly patients with indolent and aggressive non-Hodgkin lymphoma and the role of relative survival with increasing age","volume":"89","author":"Maartense","year":"2000","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdp053_bb0130","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1093\/annonc\/mdi269","article-title":"Prognostic indexes in follicular lymphoma: a comparison of different prognostic systems","volume":"16","author":"Perea","year":"2005","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdp053_bb0135","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.3324\/haematol.11502","article-title":"Prognostic relevance of serum beta2 microglobulin in patients with follicular lymphoma treated with anthracycline-containing regimens. A GISL study","volume":"92","author":"Federico","year":"2007","journal-title":"Haematologica"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419408466?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419408466?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/20\/10\/1697\/610391\/mdp053.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,23]],"date-time":"2021-06-23T09:43:06Z","timestamp":1624441386000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419408466"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":26,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["S0923753419408466"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdp053","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2009,10]]}}}